Viking Therapeutics Inc. (VKTX)
NASDAQ: VKTX
· Real-Time Price · USD
40.04
-0.20 (-0.50%)
At close: Aug 15, 2025, 3:59 PM
40.74
1.75%
After-hours: Aug 15, 2025, 07:57 PM EDT
Viking Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 436K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | 75K | 74K | 74K | 73K | 73K | 72K | 72K | 142K | n/a | 77K | 76K | 75K | 73K | 72K |
Gross Profit | n/a | n/a | n/a | -87K | -75K | -74K | 362K | -73K | -73K | -72K | -72K | -142K | n/a | -77K | -76K | -75K | -73K | -72K |
Operating Income | -74.57M | -55.47M | -46.24M | -36.56M | -34.05M | -34.07M | -29.29M | -27.27M | -23.74M | -20.54M | -20.28M | -16.2M | -17.63M | -16.25M | -12.51M | -13.4M | -15.54M | -14.23M |
Interest Income | n/a | n/a | 10.84M | 11.53M | 11.82M | 6.75M | 4.71M | 4.73M | 4.55M | 1.03M | 732K | 450K | 253K | 154K | 159K | 125K | 181K | 239K |
Pretax Income | -65.56M | -45.63M | -35.42M | -24.94M | -22.25M | -27.36M | -24.61M | -22.53M | -19.23M | -19.53M | -19.56M | -15.77M | -17.43M | -16.1M | -12.36M | -13.24M | -15.38M | -14.01M |
Net Income | -65.56M | -45.63M | -35.42M | -24.94M | -22.25M | -27.36M | -24.61M | -22.53M | -19.23M | -18.52M | -18.84M | -15.35M | -17.43M | -15.96M | -12.36M | -13.24M | -15.38M | -14.01M |
Selling & General & Admin | 14.42M | 14.08M | 15.25M | 13.77M | 10.21M | 9.97M | 8.78M | 8.89M | 9.82M | 9.53M | 4.11M | 4.24M | 4.09M | 3.69M | 2.66M | 2.61M | 2.74M | 2.69M |
Research & Development | 60.15M | 41.39M | 30.99M | 22.79M | 23.77M | 24.1M | 20.5M | 18.38M | 13.92M | 11.01M | 16.18M | 11.96M | 13.54M | 12.55M | 9.85M | 10.79M | 12.8M | 11.54M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 74.57M | 55.47M | 46.24M | 36.56M | 33.98M | 34.07M | 29.29M | 27.27M | 23.74M | 20.54M | 20.28M | 16.2M | 17.63M | 16.25M | 12.51M | 13.4M | 15.54M | 14.23M |
Interest Expense | n/a | n/a | 24K | 24K | 18K | 28K | 26K | 2K | 32K | 28K | 8K | 27K | 12K | 12K | 12K | n/a | 21K | 21K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | -75K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 55.47M | 46.24M | 36.56M | 34.05M | 34.07M | 29.29M | 27.27M | 23.74M | 20.54M | 20.28M | 16.2M | 17.63M | 16.25M | 12.51M | 13.4M | 15.54M | 14.23M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | 30.72K | n/a | -73K | -73K | -1.01M | -724K | -423K | n/a | -142K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 112.13M | 112.07M | 111.34M | 110.91M | 110.39M | 103.46M | 100.11M | 99.85M | 99.01M | 78.35M | 76.59M | 76.5M | 77.03M | 77.41M | 76.91M | 78.01M | 77.9M | 74.78M |
Shares Outstanding (Diluted) | 112.13M | 112.07M | 111.34M | 110.91M | 110.39M | 103.46M | 100.11M | 99.85M | 99.01M | 78.35M | 76.59M | 76.51M | 77.03M | 77.41M | 76.91M | 78.01M | 77.9M | 74.78M |
EPS (Basic) | -0.58 | -0.41 | -0.32 | -0.22 | -0.2 | -0.26 | -0.25 | -0.23 | -0.19 | -0.24 | -0.25 | -0.2 | -0.23 | -0.21 | -0.16 | -0.17 | -0.2 | -0.19 |
EPS (Diluted) | -0.58 | -0.41 | -0.32 | -0.22 | -0.2 | -0.26 | -0.25 | -0.23 | -0.19 | -0.24 | -0.25 | -0.2 | -0.23 | -0.21 | -0.16 | -0.17 | -0.2 | -0.19 |
EBITDA | -74.57M | -55.47M | -46.13M | -36.56M | -34.05M | -34M | -29.21M | -27.27M | -23.74M | -20.46M | -20.21M | -16.2M | -17.63M | -16.17M | -12.43M | -13.33M | -15.47M | -14.23M |
EBIT | -65.54M | -55.47M | -46.24M | -36.56M | -34.05M | -34.07M | -29.29M | -27.27M | -23.74M | -20.54M | -20.28M | -16.2M | -17.63M | -16.25M | -12.51M | -13.4M | -15.54M | -14.23M |
Depreciation & Amortization | n/a | n/a | 110K | 87K | 75K | 74K | 74K | 73K | 73K | 72K | 72K | 142K | 42K | 77K | 76K | 75K | 73K | 72K |